We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACRE
326
Ares Commercial Real Estate
ACRE
$258M
| $16.6M | 0.02% |
1,504,334
-51,268
| -3% | -$607K |
|
327
Boeing
BA
$166B
| $16.6M | 0.02% |
110,659
+3,165
| +3% | +$461K |
|
|
GPT
328
DELISTED
Gramercy Property Trust
GPT
| $16.6M | 0.02% |
196,885
-518,616
| -72% | -$14.8M |
|
329
Columbia Banking Systems
COLB
$8.51B
| $16.5M | 0.02% |
569,127
-28,689
| -5% | -$787K |
|
330
Booz Allen Hamilton
BAH
$9.05B
| $16.5M | 0.02% |
568,826
-25,041
| -4% | -$728K |
|
|
TWC
331
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $16.5M | 0.02% |
109,793
-36,899
| -25% | -$5.5M |
|
|
TGI
332
DELISTED
Triumph Group
TGI
| $16.4M | 0.02% |
274,409
-58,198
| -17% | -$3.5M |
|
|
BBG
333
DELISTED
Bill Barrett Corp
BBG
| $16.4M | 0.02% |
1,971,400
+202,500
| +11% | +$2.07M |
|
|
FGL
334
DELISTED
Fidelity & Guaranty Life
FGL
| $16.2M | 0.02% |
765,690
+202,719
| +36% | +$4.42M |
|
335
Lifecore Biomedical
LFCR
$172M
| $16.2M | 0.02% |
1,161,220
+168,899
| +17% | +$2.33M |
|
|
BMCH
336
DELISTED
BMC Stock Holdings, Inc
BMCH
| $16.2M | 0.02% |
895,453
-28,435
| -3% | -$459K |
|
|
HI
337
DELISTED
Hillenbrand
HI
| $16.1M | 0.02% |
521,621
-22,223
| -4% | -$698K |
|
|
TRIB
338
Trinity Biotech
TRIB
$7.87M
| $16M | 0.02% |
5,536
+3,779
| +215% | +$10.5M |
|
|
FCH
339
DELISTED
Felcor Lodging Trust
FCH
| $15.9M | 0.02% |
1,386,137
-180,160
| -12% | -$1.94M |
|
340
Essent Group
ESNT
$6.19B
| $15.9M | 0.02% |
664,989
+240,950
| +57% | +$5.79M |
|
|
GK
341
DELISTED
G&K Services Inc
GK
| $15.8M | 0.02% |
218,073
-10,915
| -5% | -$774K |
|
342
Radian Group
RDN
$4.82B
| $15.8M | 0.02% |
939,107
-33,761
| -3% | -$550K |
|
343
Upbound Group
UPBD
$1.12B
| $15.7M | 0.02% |
571,497
-26,772
| -4% | -$816K |
|
|
KNL
344
DELISTED
Knoll, Inc.
KNL
| $14.4M | 0.02% |
616,077
-25,429
| -4% | -$529K |
|
|
PDS
345
Precision Drilling
PDS
$1.16B
| $14.4M | 0.02% |
113,819
| – | – |
|
|
ICON
346
DELISTED
Iconix Brand Group, Inc.
ICON
| $14.4M | 0.02% |
+42,834
| New | +$14.7M |
|
347
Itaú Unibanco
ITUB
$82.7B
| $14.4M | 0.02% |
3,242,729
+251,366
| +8% | +$1.23M |
|
348
Cabot Corp
CBT
$4.32B
| $14.2M | 0.02% |
316,073
-13,030
| -4% | -$576K |
|
|
SKX
349
DELISTED
Skechers
SKX
| $14.2M | 0.02% |
591,615
-22,515
| -4% | -$484K |
|
|
SUM
350
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $14.2M | 0.02% |
+677,121
| New | +$13.8M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.